Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)
Authors not listed
National Eye Institute (NEI) · 2015
Abstract
Background:
\- People with rod-cone dystrophy (RCD) or enhanced S-cone syndrome (ESCS) have excess fluid under the retina of their eye. This can cause vision loss. The medicine interferon gamma-1b may help people with these diseases.
Objectives:
\- To see if interferon gamma-1b eyedrops are safe for people with RCD or ESCS. To see if the medicine can decrease retina fluid and help prevent vision loss.
Eligibility:
\- People at least 12 years old with RCD or ESCS. Those with ESCS must have two mutations in the NR2E3 gene.
Design:
* Participants will be screened with medical history, physical exam, eye exam, and blood tests.
* Participants will stay at NIH for 3 days and get the first eyedrops.
* Participants will give themselves 4 study eyedrops 4 times daily for 2 weeks and keep a diary.
* Participants will have 5 outpatient visits over 8 weeks, 2 of which are telephone assessments. They may have:
* Repeats of screening tests.
* Questionnaires.
* Small piece of skin removed.
* Eye exams, including eye dilation and tasks on computer screens.
* Fluorescein angiography. A dye injected into an arm vein will travel to the blood vessels in the eyes. A camera will take pictures.
* Electroretinography. Participants will sit in the dark wearing eyepatches. A small electrode will be taped to the forehead. After 30 minutes, researchers will remove the eyepatches and put in numbing eyedrops and contact lenses. Participants will watch flashing lights.
* Electrooculography. Electrodes will be attached outside of the eyes and eye function will be measured in the dark and the light.
* Participants will have a follow-up visit after 52 weeks.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-15 MST
Cite this
APA
Anonymous. (2015). Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS). <em>National Eye Institute (NEI)</em>. https://clinicaltrials.gov/study/NCT02338973
Vancouver
Anonymous. Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS). National Eye Institute (NEI). 2015.
BibTeX
@misc{anon2015PilotP,
title = {Pilot Phase I/II Study of the Evaluation of Interferon Gamma-1b Administered Topically for Macular Edema/Intraretinal Schisis Cysts in Rod-Cone Dystrophy (RCD) and Enhanced S-Cone Syndrome (ESCS)},
author = {Anonymous},
journal = {National Eye Institute (NEI)},
year = {2015},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
National Eye Institute (NEI) 2018
Open access · US-GOV
An Investigation of Vitamin A Palmitate Supplementation in Patients With Reticular Pseudodrusen (RPD) and Delayed Dark Adaptation
National Eye Institute (NEI) 2020
Open access · US-GOV
A Phase I/IIa Trial for Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration
National Eye Institute (NEI) 2001
Open access · US-GOV
A Randomized, Prospective Study of Sustained-Release Fluocinolone Acetonide Implant for Choroidal Neovascularization Associated With Age-Related Macular Degeneration
National Eye Institute (NEI) 2000
Open access · US-GOV
Evaluation and Treatment Protocol for Patients With Retinal Disease
National Institute on Aging (NIA) 2016
Open access · US-GOV
A Pilot Study of Skin Cells That Stop Replicating (Senescent) During Wound Healing
National Institute on Aging (NIA) 2014
Open access · US-GOV